Clinical trials
Observational Glomerulonephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 7 |
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 2 |
| Charite University, Berlin, Germany | 2 |
| Istanbul University | 2 |
| The George Institute | 2 |
| Alexandria University | 1 |
| AstraZeneca | 1 |
| Chen Dajin | 1 |
| Chinese University of Hong Kong | 1 |
| European Georges Pompidou Hospital | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis | 24 |
| Kidney Diseases | 6 |
| Renal Insufficiency, Chronic | 5 |
| Glomerulonephritis, IGA | 3 |
| Glomerulonephritis, Membranous | 3 |
| Glomerulosclerosis, Focal Segmental | 3 |
| Nephrosis, Lipoid | 3 |
| Diabetic Nephropathies | 2 |
| Nephrolithiasis | 2 |
| Nephrotic Syndrome | 2 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.